Biogen Inc. (BIIB) vs BioNTech SE (BNTX)
A side-by-side comparison of Biogen Inc. and BioNTech SE across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 23, 2026. Differences are shown without an overall score or investment verdict.
BIIB
Biogen Inc.
$216.78HealthcareAt close: Aug 21, 2026, 4:00 PM ET
BNTX
BioNTech SE
$116.57HealthcareAt close: Aug 21, 2026, 4:00 PM ET
Total return — BIIB vs BNTX
growth of $100 · dividends reinvested · last 7yBIIB -2.0% (-0.3%/yr)BNTX +729.5% (+35.3%/yr)BNTX compounded faster over this window
Log scale — wide-divergence pair
BIIB BNTX
BIIB vs BNTX: by the numbers
- •BIIB is the larger company ($32.03B vs $29.28B market cap).
- •BIIB is profitable (8.39% net margin) while BNTX runs a net loss (-62.98%).
- •BNTX grew revenue faster over the past five years (40.61% vs -3.19% CAGR).
Metrics side by side
Valuation
| Metric | BIIB | BNTX |
|---|---|---|
| P/E ratio | 38.37 | N/A |
| Forward P/E | 17.40 | N/A |
| P/S ratio | 3.24 | 9.53 |
| P/B ratio | 1.71 | 1.46 |
| EV / EBITDA | 22.30 | N/A |
| FCF yield | 9.21% | 2.10% |
Profitability
| Metric | BIIB | BNTX |
|---|---|---|
| Gross margin | 67.71% | 70.98% |
| Operating margin | 12.79% | -22.63% |
| Net margin | 8.39% | -62.98% |
| ROE | 4.43% | -9.62% |
| ROIC | 4.28% | -10.37% |
Growth (annualized)
| Metric | BIIB | BNTX |
|---|---|---|
| Revenue CAGR (5Y) | -3.19% | 40.61% |
| EPS CAGR (5Y) | -18.67% | N/A |
| FCF CAGR (5Y) | -11.63% | N/A |
| Total return CAGR (5Y) | -8.70% | -19.46% |
Frequently asked
- Which has grown faster, BIIB or BNTX?
- Over the past five years, BNTX grew revenue faster — BIIB at a -3.19% CAGR versus BNTX at 40.61%.
- Is BIIB or BNTX more profitable?
- BIIB runs the higher net margin — BIIB at 8.39% versus BNTX at -62.98%.
- How have BIIB and BNTX total returns compared?
- Over the past 5 years, BIIB delivered -3.72% and BNTX delivered -19.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Biogen P/E ratioBiogen ROEBioNTech SE ROEBiogen operating marginBioNTech SE operating marginBiogen revenue growthBioNTech SE revenue growthBiogen free cash flowBioNTech SE free cash flow
Biogen & BioNTech SE appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 23, 2026.